Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113334 | Critical Reviews in Oncology/Hematology | 2016 | 7 Pages |
Abstract
Short non-coding microRNAs have been identified to orchestrate crucial mechanisms in cancer progression and treatment resistance. MicroRNAs are involved in posttranscriptional modulation of gene expression and therefore represent promising targets for anticancer therapy. As mircoRNA-1 (miR-1) exerted to be predominantly downregulated in the majority of examined tumors, miR-1 is classified to be a tumor suppressor with high potential to diminish tumor development and therapy resistance. Here we review the complex functionality of miR-1 in tumor biology.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Martin Weiss, Lars-Ove Brandenburg, Martin Burchardt, Matthias B. Stope,